Eric M. Dube - CHIEF EXECUTIVE OFFICER, Director at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
TVTX on Nasdaq
All Insider Reports
All Insider Reports

Eric M. Dube - trading volume in the past year for Travere Therapeutics, Inc.

Holdings reported by Eric M. Dube for Travere Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 432,886 $14,155,372 $32.70 03 Feb 2026 Direct
Employee stock option (right to buy) 303,600 31 Jan 2026 Direct Common Stock
Performance-based restricted stock units 18,924 02 May 2025 Direct Common Stock

Transactions reported by Eric M. Dube for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.